Call for submissions on health impacts of alcohol and other drugs
A new federal parliamentary inquiry will examine the health impacts from alcohol and other drug use.
News
Researchers are using mice to study autism. But how do they know which mice are autistic?
Insight+ recently published a story about new research on the link between autism and post-traumatic stress disorder (PTSD). Readers expressed an interest (as did we) in how researchers were able to determine autism in mice. I interviewed researchers Dr Nathalie Dehorter and Dr Shaam Al Abed to find out more.
The health costs of gambling must not be ignored
The government needs to ban gambling advertising, health experts say, because the cost of gambling on the health and welfare of Australians is too high.
What’s in a name? The medical eponym dilemma
There is a longstanding tradition in the medical world of naming diseases and conditions after individuals who made valuable contributions to their discovery. But who gets to be an eponym, and who gets forgotten?
World-first program could reverse peanut allergies in babies
A world-first program is treating peanut allergies in babies under twelve months, aiming to induce remission and transform allergy care.
Older Australians facing a loneliness epidemic
Older Australians are especially vulnerable to experiencing moderate to severe loneliness, with significant economic and health consequences.
Infectious syphilis and other STIs on the rise
Sexually transmitted infections (STIs) are rising dramatically in Australia and experts worry it will lead to significant public health challenges in the future.
Health sector must lead the way for climate health equity
With planetary health and human health inextricably linked, the health sector has a vital role to play in advocating for robust climate action from our policy makers.
Multiple sclerosis research grants celebrate outside-the-box ideas
Three new incubator grants on the vanguard of medical research will search for its biological markers, improve social supports, and use AI to predict the progression of multiple sclerosis (MS)
